DCVC Bio Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
8
- Investments
-
67
- Portfolio
-
32
- Exits
-
6
DCVC Bio General Information
Company Description
Founded in 2018, DCVC Bio is a venture capital firm based in San Francisco, California. The firm invests in early-stage deep tech startups in the life sciences. These include therapeutics platforms, companies improving agriculture and food systems, and industrial biotechnologies. The firm is a group of scientists and entrepreneurs supporting companies advancing basic science, generating biological data, iterating with artificial intelligence, and automation. The firm likes teams that are unifying data to transform existing life sciences technologies and speed the development of new ones.
Business Details
Year Founded
Investor Status
Primary Investor Type
Corporate Office
- 500 2nd Street
- Floor 2
- San Francisco, CA 94107
- United States
DCVC Bio Investments (67)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Kairos Power | 16-Oct-2026 | Later Stage VC | Alternative Energy Equipment | Generating Revenue | ||
| Sabanto | 14-Jul-2026 | Machinery (B2B) | Generating Revenue | |||
| Syntax Bio | 21-Jun-2026 | Drug Discovery | Pre-Clinical Trials | |||
| Latus | 04-May-2026 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Sidewinder Therapeutics | 25-Mar-2026 | Drug Discovery | Generating Revenue | |||
| AgZen | 20-Feb-2026 | Other Hardware | Generating Revenue | |||
| Avicenna Biosciences | 28-Oct-2025 | Biotechnology | Generating Revenue | |||
| Latus | 28-Aug-2025 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Grove Biopharma | 23-Apr-2025 | Later Stage VC | Drug Discovery | Clinical Trials - General | ||
| Solu Therapeutics | 09-Apr-2025 | Early Stage VC | Drug Discovery | Clinical Trials - Phase 1 |
DCVC Bio Exits (6)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| MycoWorks | 30-Jan-2026 | Buyout/LBO | |
| Chroma Medicine | 04-Dec-2024 | ||
| Novome Biotechnologies | 03-Jul-2024 | ||
| BioPhero | 19-Jul-2022 | Merger/Acquisition | |
| AbCellera Biologics | 11-Dec-2020 | IPO |
DCVC Bio Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
DCVC Bio Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
DCVC Bio Co-Investors (172)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alexandria Venture Investments | 9 |
|
|
||
| Casdin Capital |
|
|
|||
| 5AM Ventures |
|
|
|||
| Lux Capital |
|
|
|||
| MPM BioImpact |
|
|
DCVC Bio FAQs
-
What is DCVC Bio?
Founded in 2018, DCVC Bio is a venture capital firm based in San Francisco, California.
-
When was DCVC Bio founded?
DCVC Bio was founded in 2018.
-
Where is DCVC Bio headquartered?
DCVC Bio is headquartered in San Francisco, CA.
-
What is DCVC Bio's total asset value?
DCVC Bio has around in total assets under management.
-
How many investments has DCVC Bio made?
DCVC Bio has made 67 investments.
-
What has DCVC Bio invested in?
DCVC Bio has made numerous investments in companies like Kairos Power, Sabanto, and Syntax Bio within the Alternative Energy Equipment, Machinery (B2B), and Drug Discovery industries.
-
What has DCVC Bio invested in recently?
DCVC Bio's latest investment was on 16-Oct-2026 in Kairos Power, a company within the Alternative Energy Equipment industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
